Temporal	O
Stability	O
of	O
Heavy	B:C0556345
Drinking	I:C0556345
Days	O
and	O
Drinking	O
Reductions	O
Among	O
Heavy	O
Drinkers	O
in	O
the	O
COMBINE	O
Study	I:C2603343
.	O

Temporal	O
Stability	O
of	O
Heavy	O
Drinking	I:C0556345
Days	O
and	O
Drinking	O
Reductions	B:C0441610
Among	O
Heavy	O
Drinkers	O
in	O
the	O
COMBINE	O
Study	I:C2603343
.	O

Temporal	O
Stability	O
of	O
Heavy	O
Drinking	I:C0556345
Days	O
and	O
Drinking	O
Reductions	O
Among	O
Heavy	O
Drinkers	O
in	O
the	O
COMBINE	B:C2603343
Study	I:C2603343
.	O

Recently	O
,	O
the	O
Food	B:C0041714
and	I:C0041714
Drug	I:C0041714
Administration	I:C0041714
(	O
Food	O
and	I:C0041714
Drug	I:C0041714
Administration	I:C0041714
)	O
proposed	O
to	O
expand	O
the	O
options	O
for	O
primary	O
end	O
points	O
in	O
the	O
development	O
of	O
medications	O
for	O
alcohol	O
use	O
disorder	O
to	O
include	O
either	O
abstinence	O
from	O
alcohol	O
or	O
a	O
nonabstinent	O
outcome	O
:	O
no	O
heavy	O
drinking	I:C0556345
days	O
(	O
with	O
a	O
heavy	O
drinking	I:C0556345
day	O
defined	O
as	O
more	O
than	O
3	O
drinks	O
per	O
day	O
for	O
women	O
and	O
more	O
than	O
4	O
drinks	O
per	O
day	O
for	O
men	O
[	O
>	O
3/>	O
4	O
cutoff	O
]	O
)	O
.	O

Recently	O
,	O
the	O
Food	O
and	I:C0041714
Drug	I:C0041714
Administration	I:C0041714
(	O
Food	B:C0041714
and	I:C0041714
Drug	I:C0041714
Administration	I:C0041714
)	O
proposed	O
to	O
expand	O
the	O
options	O
for	O
primary	O
end	O
points	O
in	O
the	O
development	O
of	O
medications	O
for	O
alcohol	O
use	O
disorder	O
to	O
include	O
either	O
abstinence	O
from	O
alcohol	O
or	O
a	O
nonabstinent	O
outcome	O
:	O
no	O
heavy	O
drinking	I:C0556345
days	O
(	O
with	O
a	O
heavy	O
drinking	I:C0556345
day	O
defined	O
as	O
more	O
than	O
3	O
drinks	O
per	O
day	O
for	O
women	O
and	O
more	O
than	O
4	O
drinks	O
per	O
day	O
for	O
men	O
[	O
>	O
3/>	O
4	O
cutoff	O
]	O
)	O
.	O

Recently	O
,	O
the	O
Food	O
and	I:C0041714
Drug	I:C0041714
Administration	I:C0041714
(	O
Food	O
and	I:C0041714
Drug	I:C0041714
Administration	I:C0041714
)	O
proposed	O
to	O
expand	B:C0205229
the	O
options	O
for	O
primary	O
end	O
points	O
in	O
the	O
development	O
of	O
medications	O
for	O
alcohol	O
use	O
disorder	O
to	O
include	O
either	O
abstinence	O
from	O
alcohol	O
or	O
a	O
nonabstinent	O
outcome	O
:	O
no	O
heavy	O
drinking	I:C0556345
days	O
(	O
with	O
a	O
heavy	O
drinking	I:C0556345
day	O
defined	O
as	O
more	O
than	O
3	O
drinks	O
per	O
day	O
for	O
women	O
and	O
more	O
than	O
4	O
drinks	O
per	O
day	O
for	O
men	O
[	O
>	O
3/>	O
4	O
cutoff	O
]	O
)	O
.	O

Recently	O
,	O
the	O
Food	O
and	I:C0041714
Drug	I:C0041714
Administration	I:C0041714
(	O
Food	O
and	I:C0041714
Drug	I:C0041714
Administration	I:C0041714
)	O
proposed	O
to	O
expand	O
the	O
options	O
for	O
primary	O
end	O
points	O
in	O
the	O
development	O
of	O
medications	B:C2081612
for	O
alcohol	O
use	O
disorder	O
to	O
include	O
either	O
abstinence	O
from	O
alcohol	O
or	O
a	O
nonabstinent	O
outcome	O
:	O
no	O
heavy	O
drinking	I:C0556345
days	O
(	O
with	O
a	O
heavy	O
drinking	I:C0556345
day	O
defined	O
as	O
more	O
than	O
3	O
drinks	O
per	O
day	O
for	O
women	O
and	O
more	O
than	O
4	O
drinks	O
per	O
day	O
for	O
men	O
[	O
>	O
3/>	O
4	O
cutoff	O
]	O
)	O
.	O

Recently	O
,	O
the	O
Food	O
and	I:C0041714
Drug	I:C0041714
Administration	I:C0041714
(	O
Food	O
and	I:C0041714
Drug	I:C0041714
Administration	I:C0041714
)	O
proposed	O
to	O
expand	O
the	O
options	O
for	O
primary	O
end	O
points	O
in	O
the	O
development	O
of	O
medications	O
for	O
alcohol	O
use	O
disorder	O
to	O
include	O
either	O
abstinence	O
from	O
alcohol	B:C0001967
or	O
a	O
nonabstinent	O
outcome	O
:	O
no	O
heavy	O
drinking	I:C0556345
days	O
(	O
with	O
a	O
heavy	O
drinking	I:C0556345
day	O
defined	O
as	O
more	O
than	O
3	O
drinks	O
per	O
day	O
for	O
women	O
and	O
more	O
than	O
4	O
drinks	O
per	O
day	O
for	O
men	O
[	O
>	O
3/>	O
4	O
cutoff	O
]	O
)	O
.	O

Recently	O
,	O
the	O
Food	O
and	I:C0041714
Drug	I:C0041714
Administration	I:C0041714
(	O
Food	O
and	I:C0041714
Drug	I:C0041714
Administration	I:C0041714
)	O
proposed	O
to	O
expand	O
the	O
options	O
for	O
primary	O
end	O
points	O
in	O
the	O
development	O
of	O
medications	O
for	O
alcohol	O
use	O
disorder	O
to	O
include	O
either	O
abstinence	O
from	O
alcohol	O
or	O
a	O
nonabstinent	B:C0243095
outcome	O
:	O
no	O
heavy	O
drinking	I:C0556345
days	O
(	O
with	O
a	O
heavy	O
drinking	I:C0556345
day	O
defined	O
as	O
more	O
than	O
3	O
drinks	O
per	O
day	O
for	O
women	O
and	O
more	O
than	O
4	O
drinks	O
per	O
day	O
for	O
men	O
[	O
>	O
3/>	O
4	O
cutoff	O
]	O
)	O
.	O

Recently	O
,	O
the	O
Food	O
and	I:C0041714
Drug	I:C0041714
Administration	I:C0041714
(	O
Food	O
and	I:C0041714
Drug	I:C0041714
Administration	I:C0041714
)	O
proposed	O
to	O
expand	O
the	O
options	O
for	O
primary	O
end	O
points	O
in	O
the	O
development	O
of	O
medications	O
for	O
alcohol	O
use	O
disorder	O
to	O
include	O
either	O
abstinence	O
from	O
alcohol	O
or	O
a	O
nonabstinent	O
outcome	O
:	O
no	O
heavy	B:C0556345
drinking	I:C0556345
days	O
(	O
with	O
a	O
heavy	O
drinking	I:C0556345
day	O
defined	O
as	O
more	O
than	O
3	O
drinks	O
per	O
day	O
for	O
women	O
and	O
more	O
than	O
4	O
drinks	O
per	O
day	O
for	O
men	O
[	O
>	O
3/>	O
4	O
cutoff	O
]	O
)	O
.	O

Recently	O
,	O
the	O
Food	O
and	I:C0041714
Drug	I:C0041714
Administration	I:C0041714
(	O
Food	O
and	I:C0041714
Drug	I:C0041714
Administration	I:C0041714
)	O
proposed	O
to	O
expand	O
the	O
options	O
for	O
primary	O
end	O
points	O
in	O
the	O
development	O
of	O
medications	O
for	O
alcohol	O
use	O
disorder	O
to	O
include	O
either	O
abstinence	O
from	O
alcohol	O
or	O
a	O
nonabstinent	O
outcome	O
:	O
no	O
heavy	O
drinking	I:C0556345
days	O
(	O
with	O
a	O
heavy	B:C0556345
drinking	I:C0556345
day	O
defined	O
as	O
more	O
than	O
3	O
drinks	O
per	O
day	O
for	O
women	O
and	O
more	O
than	O
4	O
drinks	O
per	O
day	O
for	O
men	O
[	O
>	O
3/>	O
4	O
cutoff	O
]	O
)	O
.	O

Recently	O
,	O
the	O
Food	O
and	I:C0041714
Drug	I:C0041714
Administration	I:C0041714
(	O
Food	O
and	I:C0041714
Drug	I:C0041714
Administration	I:C0041714
)	O
proposed	O
to	O
expand	O
the	O
options	O
for	O
primary	O
end	O
points	O
in	O
the	O
development	O
of	O
medications	O
for	O
alcohol	O
use	O
disorder	O
to	O
include	O
either	O
abstinence	O
from	O
alcohol	O
or	O
a	O
nonabstinent	O
outcome	O
:	O
no	O
heavy	O
drinking	I:C0556345
days	O
(	O
with	O
a	O
heavy	O
drinking	I:C0556345
day	O
defined	B:C1704788
as	O
more	O
than	O
3	O
drinks	O
per	O
day	O
for	O
women	O
and	O
more	O
than	O
4	O
drinks	O
per	O
day	O
for	O
men	O
[	O
>	O
3/>	O
4	O
cutoff	O
]	O
)	O
.	O

Recently	O
,	O
the	O
Food	O
and	I:C0041714
Drug	I:C0041714
Administration	I:C0041714
(	O
Food	O
and	I:C0041714
Drug	I:C0041714
Administration	I:C0041714
)	O
proposed	O
to	O
expand	O
the	O
options	O
for	O
primary	O
end	O
points	O
in	O
the	O
development	O
of	O
medications	O
for	O
alcohol	O
use	O
disorder	O
to	O
include	O
either	O
abstinence	O
from	O
alcohol	O
or	O
a	O
nonabstinent	O
outcome	O
:	O
no	O
heavy	O
drinking	I:C0556345
days	O
(	O
with	O
a	O
heavy	O
drinking	I:C0556345
day	O
defined	O
as	O
more	O
than	O
3	O
drinks	B:C0001967
per	O
day	O
for	O
women	O
and	O
more	O
than	O
4	O
drinks	O
per	O
day	O
for	O
men	O
[	O
>	O
3/>	O
4	O
cutoff	O
]	O
)	O
.	O

Recently	O
,	O
the	O
Food	O
and	I:C0041714
Drug	I:C0041714
Administration	I:C0041714
(	O
Food	O
and	I:C0041714
Drug	I:C0041714
Administration	I:C0041714
)	O
proposed	O
to	O
expand	O
the	O
options	O
for	O
primary	O
end	O
points	O
in	O
the	O
development	O
of	O
medications	O
for	O
alcohol	O
use	O
disorder	O
to	O
include	O
either	O
abstinence	O
from	O
alcohol	O
or	O
a	O
nonabstinent	O
outcome	O
:	O
no	O
heavy	O
drinking	I:C0556345
days	O
(	O
with	O
a	O
heavy	O
drinking	I:C0556345
day	O
defined	O
as	O
more	O
than	O
3	O
drinks	O
per	O
day	O
for	O
women	B:C0043210
and	O
more	O
than	O
4	O
drinks	O
per	O
day	O
for	O
men	O
[	O
>	O
3/>	O
4	O
cutoff	O
]	O
)	O
.	O

Recently	O
,	O
the	O
Food	O
and	I:C0041714
Drug	I:C0041714
Administration	I:C0041714
(	O
Food	O
and	I:C0041714
Drug	I:C0041714
Administration	I:C0041714
)	O
proposed	O
to	O
expand	O
the	O
options	O
for	O
primary	O
end	O
points	O
in	O
the	O
development	O
of	O
medications	O
for	O
alcohol	O
use	O
disorder	O
to	O
include	O
either	O
abstinence	O
from	O
alcohol	O
or	O
a	O
nonabstinent	O
outcome	O
:	O
no	O
heavy	O
drinking	I:C0556345
days	O
(	O
with	O
a	O
heavy	O
drinking	I:C0556345
day	O
defined	O
as	O
more	O
than	O
3	O
drinks	O
per	O
day	O
for	O
women	O
and	O
more	O
than	O
4	O
drinks	B:C0001967
per	O
day	O
for	O
men	O
[	O
>	O
3/>	O
4	O
cutoff	O
]	O
)	O
.	O

Recently	O
,	O
the	O
Food	O
and	I:C0041714
Drug	I:C0041714
Administration	I:C0041714
(	O
Food	O
and	I:C0041714
Drug	I:C0041714
Administration	I:C0041714
)	O
proposed	O
to	O
expand	O
the	O
options	O
for	O
primary	O
end	O
points	O
in	O
the	O
development	O
of	O
medications	O
for	O
alcohol	O
use	O
disorder	O
to	O
include	O
either	O
abstinence	O
from	O
alcohol	O
or	O
a	O
nonabstinent	O
outcome	O
:	O
no	O
heavy	O
drinking	I:C0556345
days	O
(	O
with	O
a	O
heavy	O
drinking	I:C0556345
day	O
defined	O
as	O
more	O
than	O
3	O
drinks	O
per	O
day	O
for	O
women	O
and	O
more	O
than	O
4	O
drinks	O
per	O
day	O
for	O
men	B:C0025266
[	O
>	O
3/>	O
4	O
cutoff	O
]	O
)	O
.	O

The	O
Food	B:C0041714
and	I:C0041714
Drug	I:C0041714
Administration	I:C0041714
also	O
suggested	O
that	O
6	O
months	O
would	O
be	O
the	O
most	O
appropriate	O
length	O
for	I:C1706316
a	I:C1706316
clinical	I:C1706316
trial	I:C1706316
to	O
demonstrate	O
the	O
stability	O
of	O
this	O
nonabstinent	O
drinking	O
outcome	O
.	O

The	O
Food	O
and	I:C0041714
Drug	I:C0041714
Administration	I:C0041714
also	O
suggested	O
that	O
6	O
months	O
would	O
be	O
the	O
most	O
appropriate	O
length	B:C1706316
for	I:C1706316
a	I:C1706316
clinical	I:C1706316
trial	I:C1706316
to	O
demonstrate	O
the	O
stability	O
of	O
this	O
nonabstinent	O
drinking	O
outcome	O
.	O

The	O
Food	O
and	I:C0041714
Drug	I:C0041714
Administration	I:C0041714
also	O
suggested	O
that	O
6	O
months	O
would	O
be	O
the	O
most	O
appropriate	O
length	O
for	I:C1706316
a	I:C1706316
clinical	I:C1706316
trial	I:C1706316
to	O
demonstrate	O
the	O
stability	O
of	O
this	O
nonabstinent	B:C0243095
drinking	O
outcome	O
.	O

However	O
,	O
few	O
alcohol	O
clinical	B:C0008976
trials	I:C0008976
have	O
examined	O
the	O
stability	O
of	O
nonheavy	O
drinking	I:C0556344
during	O
and	O
after	O
treatment	I:C0001758
.	O

However	O
,	O
few	O
alcohol	O
clinical	O
trials	I:C0008976
have	O
examined	B:C0332128
the	O
stability	O
of	O
nonheavy	O
drinking	I:C0556344
during	O
and	O
after	O
treatment	I:C0001758
.	O

However	O
,	O
few	O
alcohol	O
clinical	O
trials	I:C0008976
have	O
examined	O
the	O
stability	O
of	O
nonheavy	B:C0556344
drinking	I:C0556344
during	O
and	O
after	O
treatment	I:C0001758
.	O

However	O
,	O
few	O
alcohol	O
clinical	O
trials	I:C0008976
have	O
examined	O
the	O
stability	O
of	O
nonheavy	O
drinking	I:C0556344
during	O
and	O
after	B:C0001758
treatment	I:C0001758
.	O

In	O
a	O
secondary	O
analysis	O
of	O
the	O
COMBINE	B:C2603343
study	I:C2603343
data	O
(	O
n	O
=	O
1,383	O
)	O
,	O
we	O
examined	O
transitions	O
in	O
heavy	O
drinking	I:C0556345
days	O
during	O
the	O
course	O
of	O
treatment	O
(	O
months	O
1	O
through	O
4	O
)	O
,	O
during	O
the	O
transition	O
out	O
of	O
treatment	O
(	O
months	O
4	O
through	O
7	O
)	O
,	O
and	O
up	O
to	O
12	O
months	O
afterward	O
(	O
months	O
13	O
through	O
16	O
)	O
using	O
latent	O
variable	O
mixture	O
models	O
.	O

In	O
a	O
secondary	O
analysis	O
of	O
the	O
COMBINE	O
study	I:C2603343
data	O
(	O
n	O
=	O
1,383	O
)	O
,	O
we	O
examined	B:C0332128
transitions	O
in	O
heavy	O
drinking	I:C0556345
days	O
during	O
the	O
course	O
of	O
treatment	O
(	O
months	O
1	O
through	O
4	O
)	O
,	O
during	O
the	O
transition	O
out	O
of	O
treatment	O
(	O
months	O
4	O
through	O
7	O
)	O
,	O
and	O
up	O
to	O
12	O
months	O
afterward	O
(	O
months	O
13	O
through	O
16	O
)	O
using	O
latent	O
variable	O
mixture	O
models	O
.	O

In	O
a	O
secondary	O
analysis	O
of	O
the	O
COMBINE	O
study	I:C2603343
data	O
(	O
n	O
=	O
1,383	O
)	O
,	O
we	O
examined	O
transitions	O
in	O
heavy	B:C0556345
drinking	I:C0556345
days	O
during	O
the	O
course	O
of	O
treatment	O
(	O
months	O
1	O
through	O
4	O
)	O
,	O
during	O
the	O
transition	O
out	O
of	O
treatment	O
(	O
months	O
4	O
through	O
7	O
)	O
,	O
and	O
up	O
to	O
12	O
months	O
afterward	O
(	O
months	O
13	O
through	O
16	O
)	O
using	O
latent	O
variable	O
mixture	O
models	O
.	O

In	O
a	O
secondary	O
analysis	O
of	O
the	O
COMBINE	O
study	I:C2603343
data	O
(	O
n	O
=	O
1,383	O
)	O
,	O
we	O
examined	O
transitions	O
in	O
heavy	O
drinking	I:C0556345
days	O
during	O
the	O
course	O
of	O
treatment	O
(	O
months	O
1	O
through	O
4	O
)	O
,	O
during	O
the	O
transition	O
out	O
of	O
treatment	B:C0087111
(	O
months	O
4	O
through	O
7	O
)	O
,	O
and	O
up	O
to	O
12	O
months	O
afterward	O
(	O
months	O
13	O
through	O
16	O
)	O
using	O
latent	O
variable	O
mixture	O
models	O
.	O

Heavy	B:C0556345
drinking	I:C0556345
and	O
nonheavy	O
drinking	I:C0556344
were	O
relatively	O
stable	O
in	O
consecutive	O
months	O
(	O
minimum	O
agreement	O
[	O
kappa	O
]	O
=	O
0.64	O
for	O
months	O
1	O
to	O
2	O
)	O
.	O

Heavy	O
drinking	I:C0556345
and	O
nonheavy	B:C0556344
drinking	I:C0556344
were	O
relatively	O
stable	O
in	O
consecutive	O
months	O
(	O
minimum	O
agreement	O
[	O
kappa	O
]	O
=	O
0.64	O
for	O
months	O
1	O
to	O
2	O
)	O
.	O

Most	O
individuals	B:C0237401
were	O
stable	O
low	O
-	O
risk	O
drinkers	O
/	O
abstainers	O
or	O
heavy	O
drinkers	O
by	O
the	O
end	O
of	O
treatment	O
,	O
as	O
characterized	O
by	O
a	O
10	O
%	O
probability	O
(	O
or	O
less	O
)	O
of	O
transitioning	O
out	O
of	O
either	O
a	O
no	O
heavy	O
drinking	I:C0556345
state	O
or	O
a	O
heavy	O
drinking	I:C0556345
state	O
.	O

Most	O
individuals	O
were	O
stable	O
low	O
-	O
risk	O
drinkers	B:C0556338
/	O
abstainers	O
or	O
heavy	O
drinkers	O
by	O
the	O
end	O
of	O
treatment	O
,	O
as	O
characterized	O
by	O
a	O
10	O
%	O
probability	O
(	O
or	O
less	O
)	O
of	O
transitioning	O
out	O
of	O
either	O
a	O
no	O
heavy	O
drinking	I:C0556345
state	O
or	O
a	O
heavy	O
drinking	I:C0556345
state	O
.	O

Most	O
individuals	O
were	O
stable	O
low	O
-	O
risk	O
drinkers	O
/	O
abstainers	O
or	O
heavy	O
drinkers	O
by	O
the	O
end	O
of	O
treatment	B:C0087111
,	O
as	O
characterized	O
by	O
a	O
10	O
%	O
probability	O
(	O
or	O
less	O
)	O
of	O
transitioning	O
out	O
of	O
either	O
a	O
no	O
heavy	O
drinking	I:C0556345
state	O
or	O
a	O
heavy	O
drinking	I:C0556345
state	O
.	O

Most	O
individuals	O
were	O
stable	O
low	O
-	O
risk	O
drinkers	O
/	O
abstainers	O
or	O
heavy	O
drinkers	O
by	O
the	O
end	O
of	O
treatment	O
,	O
as	O
characterized	O
by	O
a	O
10	O
%	O
probability	O
(	O
or	O
less	O
)	O
of	O
transitioning	O
out	O
of	O
either	O
a	O
no	O
heavy	B:C0556345
drinking	I:C0556345
state	O
or	O
a	O
heavy	O
drinking	I:C0556345
state	O
.	O

Most	O
individuals	O
were	O
stable	O
low	O
-	O
risk	O
drinkers	O
/	O
abstainers	O
or	O
heavy	O
drinkers	O
by	O
the	O
end	O
of	O
treatment	O
,	O
as	O
characterized	O
by	O
a	O
10	O
%	O
probability	O
(	O
or	O
less	O
)	O
of	O
transitioning	O
out	O
of	O
either	O
a	O
no	O
heavy	O
drinking	I:C0556345
state	O
or	O
a	O
heavy	B:C0556345
drinking	I:C0556345
state	O
.	O

More	O
than	O
two	O
-	O
thirds	O
of	O
the	O
heavy	O
drinkers	O
who	O
exceeded	O
the	O
heavy	B:C0556345
drinking	I:C0556345
threshold	O
during	O
treatment	O
reported	O
,	O
on	O
average	O
,	O
a	O
64	O
%	O
reduction	O
in	O
drinking	O
frequency	I:C0556327
and	O
a	O
38	O
%	O
reduction	O
in	O
drinking	O
intensity	O
from	O
pretreatment	O
drinking	O
levels	O
.	O

More	O
than	O
two	O
-	O
thirds	O
of	O
the	O
heavy	O
drinkers	O
who	O
exceeded	O
the	O
heavy	O
drinking	I:C0556345
threshold	O
during	O
treatment	O
reported	B:C0700287
,	O
on	O
average	O
,	O
a	O
64	O
%	O
reduction	O
in	O
drinking	O
frequency	I:C0556327
and	O
a	O
38	O
%	O
reduction	O
in	O
drinking	O
intensity	O
from	O
pretreatment	O
drinking	O
levels	O
.	O

More	O
than	O
two	O
-	O
thirds	O
of	O
the	O
heavy	O
drinkers	O
who	O
exceeded	O
the	O
heavy	O
drinking	I:C0556345
threshold	O
during	O
treatment	O
reported	O
,	O
on	O
average	O
,	O
a	O
64	O
%	O
reduction	B:C0441610
in	O
drinking	O
frequency	I:C0556327
and	O
a	O
38	O
%	O
reduction	O
in	O
drinking	O
intensity	O
from	O
pretreatment	O
drinking	O
levels	O
.	O

More	O
than	O
two	O
-	O
thirds	O
of	O
the	O
heavy	O
drinkers	O
who	O
exceeded	O
the	O
heavy	O
drinking	I:C0556345
threshold	O
during	O
treatment	O
reported	O
,	O
on	O
average	O
,	O
a	O
64	O
%	O
reduction	O
in	O
drinking	B:C0556327
frequency	I:C0556327
and	O
a	O
38	O
%	O
reduction	O
in	O
drinking	O
intensity	O
from	O
pretreatment	O
drinking	O
levels	O
.	O

More	O
than	O
two	O
-	O
thirds	O
of	O
the	O
heavy	O
drinkers	O
who	O
exceeded	O
the	O
heavy	O
drinking	I:C0556345
threshold	O
during	O
treatment	O
reported	O
,	O
on	O
average	O
,	O
a	O
64	O
%	O
reduction	O
in	O
drinking	O
frequency	I:C0556327
and	O
a	O
38	O
%	O
reduction	B:C0441610
in	O
drinking	O
intensity	O
from	O
pretreatment	O
drinking	O
levels	O
.	O

The	O
results	B:C0456984
show	O
stability	O
of	O
no	O
heavy	O
drinking	I:C0556345
as	O
an	O
outcome	O
within	O
the	O
first	O
4	O
months	O
of	O
treatment	O
and	O
that	O
the	O
>	O
3	O
/	O
>	O
4	O
drink	O
cutoff	O
may	O
mask	O
substantial	O
reductions	O
in	O
alcohol	O
consumption	O
among	O
some	O
patients	O
.	O

The	O
results	O
show	O
stability	O
of	O
no	O
heavy	B:C0556345
drinking	I:C0556345
as	O
an	O
outcome	O
within	O
the	O
first	O
4	O
months	O
of	O
treatment	O
and	O
that	O
the	O
>	O
3	O
/	O
>	O
4	O
drink	O
cutoff	O
may	O
mask	O
substantial	O
reductions	O
in	O
alcohol	O
consumption	O
among	O
some	O
patients	O
.	O

The	O
results	O
show	O
stability	O
of	O
no	O
heavy	O
drinking	I:C0556345
as	O
an	O
outcome	O
within	O
the	O
first	O
4	O
months	O
of	O
treatment	B:C0087111
and	O
that	O
the	O
>	O
3	O
/	O
>	O
4	O
drink	O
cutoff	O
may	O
mask	O
substantial	O
reductions	O
in	O
alcohol	O
consumption	O
among	O
some	O
patients	O
.	O

The	O
results	O
show	O
stability	O
of	O
no	O
heavy	O
drinking	I:C0556345
as	O
an	O
outcome	O
within	O
the	O
first	O
4	O
months	O
of	O
treatment	O
and	O
that	O
the	O
>	O
3	O
/	O
>	O
4	O
drink	B:C0001967
cutoff	O
may	O
mask	O
substantial	O
reductions	O
in	O
alcohol	O
consumption	O
among	O
some	O
patients	O
.	O

The	O
results	O
show	O
stability	O
of	O
no	O
heavy	O
drinking	I:C0556345
as	O
an	O
outcome	O
within	O
the	O
first	O
4	O
months	O
of	O
treatment	O
and	O
that	O
the	O
>	O
3	O
/	O
>	O
4	O
drink	O
cutoff	O
may	O
mask	O
substantial	O
reductions	B:C0441610
in	O
alcohol	O
consumption	O
among	O
some	O
patients	O
.	O

Future	O
studies	B:C2603343
should	O
explore	O
the	O
clinical	O
utility	O
of	O
reduction	O
end	O
points	O
.	O

Future	O
studies	O
should	O
explore	O
the	O
clinical	O
utility	O
of	O
reduction	B:C0441610
end	O
points	O
.	O

